+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma



Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma



Dermatology Nursing 21(2): 86-87



An 85-year-old female presented to the office with a 3.5 x 2 cm basal cell carcinoma on her left neck. After the patient refused all conventional interventions, topical treatment with imiquimod 5% cream was initiated. Although not indicated for treating nodular basal cell carcinomas, imiquimod may be a viable option for large basal cell carcinomas when patients are unable or unwilling to have surgical interventions.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 051965595

Download citation: RISBibTeXText

PMID: 19507375


Related references

Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area. Indian Journal of Ophthalmology 65(1): 48-51, 2017

Imiquimod 5% Cream as Pre-Treatment of Mohs Micrographic Surgery for Nodular Basal Cell Carcinoma in the Face, A Prospective Randomized Controlled Study Imiquimod As Pre-Treatment of Mohs. 2012

Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial. Bmc Ophthalmology 15: 35, 2015

Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Archives of Dermatology 138(9): 1165-1171, 2002

Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream. Dermatology Online Journal 14(2): 25, 2008

Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage. Journal of Drugs in Dermatology 6(9): 910-914, 2007

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: Randomized studies comparing low-frequency dosing with and without occlusion. British Journal of Dermatology 147(6): 1227-1236, 2002

5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Archives of Dermatology 140(10): 1286-1287, 2004

An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma. Australasian Journal of Dermatology 47(1): 46-48, 2006

Immunotherapy With Imiquimod 5% Cream for Eyelid Nodular Basal Cell Carcinoma. Yearbook of Ophthalmology 2007: 231-232, 2007

Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma. American Journal of Ophthalmology 140(6): 1136-1139, 2005

Resolution of tinea pedis with imiquimod cream 5% in a patient with nodular basal cell carcinoma. Cutis 78(1): 66-69, 2006

Ulcerated nodular nasal basal cell carcinoma successfully treated with imiquimod 5% cream. Journal of Drugs in Dermatology 10(3): 240-241, 2011

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. Journal of the American Academy of Dermatology 57(4): 616-621, 2007

Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma. Dermatologic Surgery 32(1): 63-69, 2006